Danaher Corporation Set to Showcase Innovations at Upcoming Global Healthcare Conferences

On November 2, 2026, Danaher Corporation (NYSE: DHR) announced an exciting lineup for its upcoming presentations at two significant global healthcare conferences. Danaher's President and CEO, Julie Sawyer Montgomery, will deliver keynote speeches, providing insights into the company’s latest advancements in life sciences, diagnostics, and biotechnology.

Conference Details

UBS Global Healthcare Conference

Montgomery will kick off Danaher's presentations on November 9, 2026, at the UBS Global Healthcare Conference in Palm Beach, Florida. This event marks an opportunity for Danaher to connect with industry leaders, investors, and healthcare professionals, discussing the company's innovative solutions and their impact on health outcomes.

The presentation is scheduled for 11:45 a.m. ET and will also be accessible via a live webcast on the official Danaher website, allowing global audiences to participate in the conversation surrounding healthcare advancements.

Jefferies Global Healthcare Conference

Following the UBS event, Danaher will present at the Jefferies Global Healthcare Conference in London, UK, on November 17, 2026, at 10:00 a.m. GMT. This conference serves as a platform for Danaher to share continued progress in scientific innovation and operational excellence. The London presentation will also be made available through a simultaneous webcast, reinforcing Danaher’s commitment to transparency and stakeholder engagement.

About Danaher Corporation

Danaher is recognized as a leading global innovator in life sciences, diagnostics, and biotechnology. The company is dedicated to leveraging the power of science and technology to improve human health worldwide. With a diverse portfolio of industry-leading businesses, Danaher collaborates closely with its customers to address complex scientific challenges.

Driving these efforts is the Danaher Business System, which promotes continuous improvement and operational excellence among its workforce of 60,000 associates worldwide. This system embodies the company's philosophy of fostering innovation and enhancing the pace of scientific discovery, thereby delivering life-changing therapies to those in need.

As global health challenges evolve, Danaher remains agile, aiming to deliver breakthrough solutions that accelerate the speed of research and discovery in healthcare. Among the company's recent initiatives is a significant collaboration with NVIDIA to advance autonomous science, further solidifying its role as a leader in technological innovation.

For more information on Danaher Corporation and its participation in the upcoming conferences, visit their official website at www.danaher.com. Here, stakeholders can find resources, news updates, and details about the company’s ongoing projects and contributions to healthcare.

Conclusion

As Danaher prepares to take center stage at these influential events, industry watchers and stakeholders will undoubtedly be keen to see how the company continues to push boundaries in healthcare innovation. This announcement not only highlights Danaher’s commitment to advancing science and medicine but also signifies the importance of industry dialogue in addressing today’s critical health concerns.